Valesano Andrew L, Rumfelt Kalee E, Dimcheff Derek E, Blair Christopher N, Fitzsimmons William J, Petrie Joshua G, Martin Emily T, Lauring Adam S
Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USA.
bioRxiv. 2021 Jan 20:2021.01.19.427330. doi: 10.1101/2021.01.19.427330.
Analysis of SARS-CoV-2 genetic diversity within infected hosts can provide insight into the generation and spread of new viral variants and may enable high resolution inference of transmission chains. However, little is known about temporal aspects of SARS-CoV-2 intrahost diversity and the extent to which shared diversity reflects convergent evolution as opposed to transmission linkage. Here we use high depth of coverage sequencing to identify within-host genetic variants in 325 specimens from hospitalized COVID-19 patients and infected employees at a single medical center. We validated our variant calling by sequencing defined RNA mixtures and identified a viral load threshold that minimizes false positives. By leveraging clinical metadata, we found that intrahost diversity is low and does not vary by time from symptom onset. This suggests that variants will only rarely rise to appreciable frequency prior to transmission. Although there was generally little shared variation across the sequenced cohort, we identified intrahost variants shared across individuals who were unlikely to be related by transmission. These variants did not precede a rise in frequency in global consensus genomes, suggesting that intrahost variants may have limited utility for predicting future lineages. These results provide important context for sequence-based inference in SARS-CoV-2 evolution and epidemiology.
分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在受感染宿主内的基因多样性,有助于深入了解新病毒变种的产生和传播,并可能实现对传播链的高分辨率推断。然而,对于SARS-CoV-2宿主内多样性的时间动态以及共享多样性在多大程度上反映趋同进化而非传播联系,我们了解甚少。在此,我们利用高深度测序来识别一家医疗中心325份来自住院COVID-19患者和受感染员工的样本中的宿主内基因变异。我们通过对定义的RNA混合物进行测序验证了变异检测,并确定了一个能使假阳性最小化的病毒载量阈值。通过利用临床元数据,我们发现宿主内多样性较低,且不会因症状出现后的时间而变化。这表明变异在传播之前很少会上升到可观的频率。尽管在整个测序队列中通常很少有共享变异,但我们在不太可能因传播而相关的个体中发现了共享的宿主内变异。这些变异在全球共识基因组中的频率上升之前并未出现,这表明宿主内变异在预测未来谱系方面的作用可能有限。这些结果为SARS-CoV-2进化和流行病学中基于序列的推断提供了重要背景。